Involvement of bystander effect in suppression of the cytokine production induced by heavy-ion broad beams

International Journal of Radiation Biology

Volumn 88, Issue 3, 2012, Pages 258-266

  Mutou Yoshihara, Yasuko ^a   Funayama, Tomoo ^a   Yokota, Yuichiro ^a   Kobayashi, Yasuhiko ^a  

^a JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

Bystander effect; Heavy ion; Interleukin 6; Nitric oxide; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BYSTANDER EFFECT; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEAVY ION RADIATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; ION THERAPY; LEUKEMIA CELL LINE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; RADIATION DOSE;

BYSTANDER EFFECT; CARBON; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; HEAVY IONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; NITRIC OXIDE; NITRITES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857845463     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.636138     Document Type: Article

References (32)

1. Conrad S, Ritter S, Fournier C, Nixdorf K. 2009. Dif erential effects of irradiation with carbon ions and X-rays on macrophage function. Journal of Radiation Research 50:223-231.
2. Elsea CR, Roberts DA, Druker BJ, Wood LJ. 2008. Inhibition of p38 MAPK suppresses inf ammatory cytokine induction by etoposide, 5-f uorouracil, and doxorubicin without af ecting tumoricidal activity. Anticancer Drugs & Cytokines 3:e2355.
3. Fang SP, Tago F, Tanaka T, Simura N, Muto Y, Goto R, Kojima S. 2005. Repeated irradiations with gamma-rays at a dose of 0.5 Gy may exacerbate asthma. Journal of Radiation Research 46:151-156. (Pubitemid 41190650)
4. Formenti SC, Demaria S. 2009. Systemic effects of local radiotherapy. The Lancet Oncology 10:718-726.
5. Funayama T, Wada S, Yokota Y, Fukamoto K, Sakashita T, Taguchi M, Kakizaki T, Hamada N, Suzuki M, Furusawa Y, Watanabe H, Kiguchi K, Kobayashi Y. 2008. Heavy-ion microbeam system at JAEA-Takasaki for microbeam biology. Journal of Radiation Research 49:71-82. (Pubitemid 351214420)
6. Goto H, Prianti MG. 2009. Immunoactivation and immunopathogeny during active visceral leishmaniasis. Revista do Instituto de Medic-ina Tropical de São Paulo 51:241-246.
7. Guicciardi ME, Gores GJ. 2003. AIP1: A new player in TNF signaling. The Journal of Clinical Investigation 111:1813-1815.
8. Gutierrez FR, Mineo TW, Pavanelli WR, Guedes PM, Silva JS. 2009. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Memórias do Instituto Oswaldo Cruz 104:236-245.
9. Guzik TJ, Korbut R, Adamek-Guzik T. 2003. Nitric oxide and superoxide in inf ammation and immune regulation. Journal of Physiology and Pharmacology 54:469-487. (Pubitemid 38029745)
10. Hamada N, Hara T, Omura-Minamisawa M, Ni M, Funayama T, Sakashita T, Sora1 S, Nakano T, Kobayashi Y. 2008a. Heavy-ion microbeam irradiation induces bystander killing of human cells. Biological Sciences in Space 22:46-53.
11. Hamada N, Ni M, Funayama T, Sakashita T, Sora S, Nakano T, Kobayashi Y. 2008b. A LET-dependent decrease in the apoptotic response of normal human f broblast cultures to isosurvival doses of gamma-rays and energetic heavy ions. Biological Sciences in Space 22:41-45.
12. Hamada N, Ni M, Funayama T, Sakashita T, Kobayashi Y. 2008c. Temporally distinct response of irradiated normal human f broblasts and their bystander cells to energetic heavy ions. Mutation Research 639:35-44.
13. Iwakawa M, Hamada N, Imadome K, Funayama T, Sakashita T, Kobayashi Y, Imai T. 2008. Expression profiles are dif erent in carbon ion-irradiated normal human f broblasts and their bystander cells. Mutation Research 642:57-67.
14. Jäkel O, Schulz-Ertner D, Karger CP, Nikoghosyan A, Debus J. 2003. Heavy ion therapy: Status and perspectives. Technology in Cancer Research & Treatment 2:377-387. (Pubitemid 37362995)
15. Kirkwood KL, Rossa C Jr. 2009. The potential of p38 MAPK inhibitors to modulate periodontal infections. Current Drug Metabolism 10: 55-67.
16. Kleemann R, Zadelaar S, Kooistra T. 2008. Cytokines and atherosclerosis: A comprehensive review of studies in mice. Cardiovascular Research 79:360-376.
17. Kobayashi Y, Funayama T, Wada S, Furusawa Y, Aoki M, Shao C, Yokota Y, Sakashita T, Matsumoto Y, Kakizaki T, Hamada N. 2004. Microbeams of heavy charged particles. Biological Sciences in Space 18:235-240.
18. Königshof M, Kneidinger N, Eickelberg O. 2009. TGF-beta signaling in COPD: Deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Medical Weekly 139:554-563.
19. Kunz M, Ibrahim SM. 2009. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inf ammation 2009:979258.
20. Kwon OJ. 1997. The role of nitric oxide in the immune response of tuberculosis. The Journal of Korean Medical Science 12:481-487. (Pubitemid 127711382)
21. Lorimore SA, Chrystal JA, Robinson JI, Coates PJ, Wright EG. 2008. Chromosomal instability in unirradiated hematopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Research 68:8122-8126.
22. Majdalawieh A, Ro HS. 2010. Regulation of IKBCX function and NF-KB signaling: AEBP1 is a novel proinf ammatory mediator in macrophages. Mediators of Inf ammation 2010:823821.
23. Matsumoto H, Hayashi S, Jin ZH, Hatashita M, Ohtsubo T, Ohnishi T, Kano E. 2002. Intercellular signaling mediated by nitric oxide in human glioblastoma cells. Methods in Enzymology 359:280-286. (Pubitemid 35387030)
24. Matsumoto H, Tomita M, Otsuka K, Hatashita M. 2009. A new paradigm in radioadaptive response developing from microbeam research. Journal of Radiation Research 50:A67-79.
25. Narang H, Bhat N, Gupta SK, Santra S, Choudhary RK, Kailash S, Krishna M. 2009. Dif erential activation of mitogen-activated protein kinases following high and low LET radiation in murine macrophage cell line. Molecular and Cellular Biochemistry 324:85-91.
26. Peters T, Bloch W, Wickenhauser C, Tawadros S, Oreshkova T, Kess D, Krieg T, Müller W, Scharf etter-Kochanek K. 2006. Terminal B cell dif erentiation is skewed by deregulated interleukin-6 secretion in beta2 integrin-def cient mice. Journal ofileukocyte Biology 80: 599-607. (Pubitemid 44835794)
27. Simmonds RE, Foxwell BM. 2008. Signalling, inf ammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology 47:584-590. (Pubitemid 351619194)
28. Stienstra Y, van der Graaf WT, The Meerman GJ, The TH, de Leij LF, van der Werf TS. 2001. Susceptibility to development of Mycobacterium ulcerans disease: Review of possible risk factors. Tropical Medicine International Health 6:554-562. (Pubitemid 32664639)
29. Tsukimoto M, Homma T, Mutou Y, Kojima S. 2009. 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiation Research 171:219-224.
30. Turner NA, Mughal RS, Warburton P, O'Regan DJ, Ball SG, Porter KE. 2007. Mechanism of TNF-a-induced IL-1a, IL-1|5 and IL-6 expression in human cardiac fibroblasts: Effects of statins and thiazolidinediones. Cardiovascular Research 76:81-90. (Pubitemid 47362045)
31. van Horssen R, ten Hagen TL, Eggermont AM. 2006. TNF-a in cancer treatment: Molecular insights, antitumor effects, and clinical utility. The Oncologist 11:397-408.
32. Zhou JY, Liu Y, Wu GS. 2006. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Research 66:4888-4894.